Home›Companies›Healthcare›Bright Point Medical

Lumoptik, Inc.

Lumoptik develops needle guidance devices to help physicians perform epidural procedures.

Updated Nov 9, 2026·Latest SEC filing Sep 18, 2026·Suggest an edit

About Bright Point Medical

Bright Point Medical is a private company based in Washington Island, Wisconsin. It has reported $2,536,879 raised in three offerings on Form D since June 2019.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 16, 2026Sep 18, 2026$1,536,879of $2.2M target73$21,053EquityRule 506(b)Form D ↗
Mar 1, 2021Nov 15, 2021$900,000of $1.5M target29$31,034EquityRule 506(b)Form D ↗
May 21, 2019Jun 3, 2019$100,000of $1.5M target2$50,000Options, Simple Agreement for Future EquityRule 506(b)Form D ↗
Total, three offerings$2,536,879

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Bright Point Medical's Form D filed Sep 18, 2026.

JE
Jeff Enslin
Director
CH
JL
Jonathan Lamb
Chief Financial Officer
NR
AH
BK
Brian Kearns
Director

Earlier filings also listed Thomas Janicki (director, last listed Nov 2021), Schumann Robert (director, last listed Nov 2021), Kurtz Sanford (director, last listed Nov 2021), Frank Lyman (executive officer and director, last listed Nov 2021), Don Verlee (executive officer, last listed Nov 2021), Andy Alexander (executive officer, last listed Nov 2021) and Arthur Janicki (director, last listed Jun 2019).

Sources

  1. SECLumoptik, Inc. filing history
  2. CompanyBright Point Medical about
  3. PressHospital for Special Surgery and Lumoptik announcement